What Ahren Innovation Capital does

Ahren Innovation Capital is a London- and Cambridge-based venture capital firm founded in 2018 by Alice Newcombe-Ellis, structured as a UK limited liability partnership (Ahren Innovation Capital LLP) and operating its flagship fund, Ahren LP. The firm invests in early- to growth-stage companies at the intersection of deep technology and deep science, organized across four stated domains: Brain & AI, Genetics & Platform Technologies, Space & Robotics, and Efficient Energy. Ahren backs founders from pre-seed through pre-IPO, both building companies from scratch alongside its Science Partners and providing capital and expertise to high-growth businesses.

The firm's distinguishing structural feature is its partnership with a panel of Founding Science Partners — including Nobel laureates Sir Gregory Winter and Sir Venki Ramakrishnan, Sir Shankar Balasubramanian, Professor John Daugman, Professor Zoubin Ghahramani, Professor Steve Jackson, Professor Andy Parker, and Lord Martin Rees — whose underlying technologies are reportedly valued in excess of $100BN combined (e.g., Solexa sequencing, IRIS recognition, Olaparib/Lynparza, phage display/Humira). This network provides differentiated deal sourcing, technical due diligence, and co-creation of companies such as Bicycle Therapeutics, Cambridge Epigenetix, Adrestia, and Constructive Bio.

Ahren's economic model is conventional venture fund management: management fees and carried interest on committed and deployed capital. The firm completed a first close above $100M in 2018, a final close above $250M in 2019, and is currently investing from a new fund with over $400M in dry powder. Institutional Limited Partners include Aviva and Wittington Investments, alongside US family offices. Notable portfolio outcomes include the Graphcore Series D at a $1.7BN unicorn valuation, Adrestia's acquisition by Insmed for $72.4M plus milestones, and 6D.ai's acquisition by Niantic; the active portfolio spans at least 20 named companies across AI compute, foundation models, synthetic biology, quantum networking, robotics, direct air capture, and cellular agriculture.

Name

Ahren Innovation Capital

Legal name

Ahren Innovation Capital LLP

Website

https://ahreninnovationcapital.com

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

Ahren Innovation Capital is a UK-based deep tech and deep science venture capital firm that backs exceptional founders across AI, genetics, space/robotics, and efficient energy from pre-seed to pre-IPO, supported by a unique partnership of Nobel-laureate Science Partners.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Other Investment Pools and Funds (5259)

SIC

Investment Advice (6282), Investors, Nec (6799)

akta.pro primary industry

Early-Stage Venture Capital (Pre-Seed/Seed) (FSANAAAA)

Keywords

• Venture capital
• Deep tech investing
• Deep science investing
• Early stage funding
• Technology investment

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Investment Returns: Returns generated through equity investments in portfolio companies across various funding stages, from pre-seed to pre-IPO. Returns realized through exits via acquisitions, IPOs, and secondary sales.
2. Fund Management: Management fees and carried interest from managing investment funds. Fund closed at over $250 million.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Ahren Innovation Capital is an investment institution that supports transformational companies at the intersection of deep tech and deep science. It provides both patient and active capital to exceptional founders and teams at all stages from pre-seed to pre-IPO, investing across four domains: Brain & AI, Genetics & Platform Technologies, Space & Robotics, and Efficient Energy. The firm operates from London and Cambridge with a latest fund containing over $400M in dry powder.

Product overview

Ahren Innovation Capital is a deep technology and deep science investment firm that provides capital and support to transformational companies. As an investment institution rather than a product company, Ahren does not offer standalone products, platforms, or services to external customers. The firm focuses on four investment domains: Brain & AI, Genetics & Platform Technologies, Space & Robotics, and Efficient Energy, supporting portfolio companies from pre-seed to pre-IPO stages.

Differentiator

Problem solved

Functional benefit

Products and services

• Ahren LP Fund Venture capital fund providing patient and active equity capital to transformational deep tech and deep science companies from pre-seed to pre-IPO stages. The latest fund has over $400M in dry powder for investments across Brain & AI, Genetics & Platform Technologies, Space & Robotics, and Efficient Energy. Targeted at institutional Limited Partners and exceptional founders.

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• GSKcoreStrategic or Co-development PartnerGSK co-led Series A investment in Adrestia with Ahren and established a multi-project discovery collaboration. Each project eligible to receive up to $230M in post-option milestones.

Scale indicators5 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Lux Capital: US-based deep tech and science-focused venture capital firm investing across similar domains (AI, robotics, space, energy) with a strong academic and scientific advisor network. Directly comparable as a deep tech specialist VC.
• DCVC (Deep Capital): Deep tech and computational science venture capital firm focused on AI, life sciences, energy, and materials. Closely comparable in stage-agnostic deep tech investing and science-driven thesis.
• Atomico: London-based European venture capital firm investing across tech stages with strong founder support programs. Comparable as a European-headquartered stage-agnostic VC, though Ahren is more science/deep tech focused.
• Balderton Capital: London-based early-stage venture capital firm focused on European technology companies. Comparable in UK base, stage-agnostic seed/Series A focus, and commitment to deep tech and science-adjacent sectors.
• Playground Global: US deep tech venture capital firm investing in frontier technology including AI, robotics, advanced materials, and energy. Directly comparable as deep tech specialist with patient capital and technical due diligence.
• Obvious Ventures: Venture capital firm investing in purpose-driven and science-based companies across health, climate, and technology. Comparable in mission-driven, science-rooted investment approach.
• Section 32: Venture fund founded by Bill Maris (ex-Google Ventures) focused on biotech, healthcare, and frontier technology. Comparable in science-driven early-stage investing with high-profile science connections.
• Northzone: European venture capital firm with stage-agnostic investments across tech, with strong London/Stockholm presence. Comparable as European stage-agnostic VC with growing deep tech exposure.

Broad incumbents

• Khosla Ventures: Large US venture firm with one of the most aggressive deep tech and science investment strategies globally. Comparable in deep tech focus and willingness to invest at seed through growth, though much larger AUM.
• Index Ventures: Major European-headquartered venture capital firm investing from seed to growth across tech. Comparable in stage-agnostic approach and London presence, though broader sector mandate than Ahren.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/AhrenLP
• LinkedInlinkedin.com/organization-guest/company/ahren-innovation-capital

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments45 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ahren Innovation Capital